These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17392284)

  • 1. The carboxyl-terminal fragment of pro-HB-EGF reverses Bcl6-mediated gene repression.
    Kinugasa Y; Hieda M; Hori M; Higashiyama S
    J Biol Chem; 2007 May; 282(20):14797-806. PubMed ID: 17392284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers.
    Hirata Y; Ogasawara N; Sasaki M; Mizushima T; Shimura T; Mizoshita T; Mori Y; Kubota E; Wada T; Tanida S; Kataoka H; Kamiya T; Higashiyama S; Joh T
    Br J Cancer; 2009 Apr; 100(8):1320-9. PubMed ID: 19337254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle.
    Toki F; Nanba D; Matsuura N; Higashiyama S
    J Cell Physiol; 2005 Mar; 202(3):839-48. PubMed ID: 15389565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
    Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
    Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membrane.
    Hieda M; Isokane M; Koizumi M; Higashi C; Tachibana T; Shudou M; Taguchi T; Hieda Y; Higashiyama S
    J Cell Biol; 2008 Feb; 180(4):763-9. PubMed ID: 18299347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells.
    Ozeki K; Tanida S; Morimoto C; Inoue Y; Mizoshita T; Tsukamoto H; Shimura T; Kataoka H; Kamiya T; Nishiwaki E; Ishiguro H; Higashiyama S; Joh T
    PLoS One; 2013; 8(2):e56770. PubMed ID: 23451083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF.
    Nanba D; Mammoto A; Hashimoto K; Higashiyama S
    J Cell Biol; 2003 Nov; 163(3):489-502. PubMed ID: 14597771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion.
    Shimura T; Yoshida M; Fukuda S; Ebi M; Hirata Y; Mizoshita T; Tanida S; Kataoka H; Kamiya T; Higashiyama S; Joh T
    BMC Cancer; 2012 May; 12():205. PubMed ID: 22646534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic domain phosphorylation of heparin-binding EGF-like growth factor.
    Wang X; Mizushima H; Adachi S; Ohishi M; Iwamoto R; Mekada E
    Cell Struct Funct; 2006; 31(1):15-27. PubMed ID: 16557002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
    Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
    Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells.
    Wang F; Sloss C; Zhang X; Lee SW; Cusack JC
    Cancer Res; 2007 Sep; 67(18):8486-93. PubMed ID: 17875687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
    Umata T; Hirata M; Takahashi T; Ryu F; Shida S; Takahashi Y; Tsuneoka M; Miura Y; Masuda M; Horiguchi Y; Mekada E
    J Biol Chem; 2001 Aug; 276(32):30475-82. PubMed ID: 11402047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascades.
    Takenobu H; Yamazaki A; Hirata M; Umata T; Mekada E
    J Biol Chem; 2003 May; 278(19):17255-62. PubMed ID: 12611888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface.
    Chen X; Raab G; Deutsch U; Zhang J; Ezzell RM; Klagsbrun M
    J Biol Chem; 1995 Aug; 270(31):18285-94. PubMed ID: 7629148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme.
    Nishi E; Hiraoka Y; Yoshida K; Okawa K; Kita T
    J Biol Chem; 2006 Oct; 281(41):31164-72. PubMed ID: 16923819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-terminal deletion of heparin-binding epidermal growth factor-like growth factor4-127 stimulates cell proliferation but lacks insulin-like activity.
    Zhou Z; Harding PA
    Cell Prolif; 2007 Apr; 40(2):213-30. PubMed ID: 17472728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
    Miyamoto S; Hirata M; Yamazaki A; Kageyama T; Hasuwa H; Mizushima H; Tanaka Y; Yagi H; Sonoda K; Kai M; Kanoh H; Nakano H; Mekada E
    Cancer Res; 2004 Aug; 64(16):5720-7. PubMed ID: 15313912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor-like growth factor.
    Mehta VB; Besner GE
    J Immunol; 2003 Dec; 171(11):6014-22. PubMed ID: 14634113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism.
    Fernández de Mattos S; Essafi A; Soeiro I; Pietersen AM; Birkenkamp KU; Edwards CS; Martino A; Nelson BH; Francis JM; Jones MC; Brosens JJ; Coffer PJ; Lam EW
    Mol Cell Biol; 2004 Nov; 24(22):10058-71. PubMed ID: 15509806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
    Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
    J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.